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Abstract: Glutathionylation, that is, the formation of mixed disulfides between protein cysteines and
glutathione (GSH) cysteines, is a reversible post-translational modification catalyzed by different
cellular oxidoreductases, by which the redox state of the cell modulates protein function. So far, most
studies on the identification of glutathionylated proteins have focused on cellular proteins, including
proteins involved in host response to infection, but there is a growing number of reports showing
that microbial proteins also undergo glutathionylation, with modification of their characteristics and
functions. In the present review, we highlight the signaling role of GSH through glutathionylation,
particularly focusing on microbial (viral and bacterial) glutathionylated proteins (GSSPs) and host
GSSPs involved in the immune/inflammatory response to infection; moreover, we discuss the
biological role of the process in microbial infections and related host responses.
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1. Introduction
Glutathione, Cellular Thiols, and Glutathionylation
The tripeptide γ-l-glutamyl-l-cysteinyl-glycine, or glutathione (GSH), is the most abundant
eukaryotic intracellular thiol, found in a concentration range of 1–10 mM. It is mainly localized in the
cytosol (up to 90%), but it is also present in the mitochondria (10%), the endoplasmic reticulum, and
the nucleus in a small percentage [1]. The antioxidant activity of GSH is probably the best known
and popular function of this molecule; in fact, thanks to the reactivity and the reducing ability of
its cysteinyl residue’s sulfhydryl (-SH) group, it can quickly react with and neutralize potentially
dangerous molecules, both of endogenous and exogenous origin, as reactive oxygen and nitrogen
species (ROS and RNS, respectively), xenobiotics, and metals [2].
However, today it is well known that the essential role of GSH overcomes its scavenger activity
and it plays a crucial role in cell fate, regulating processes such as proliferation, differentiation, and
apoptosis, and several other cellular functions, ranging from metabolism to immune and inflammatory
response [3–6]. In fact, the concentration of GSH and its oxidized form, glutathione disulfide
(GSSG), mainly determines the redox state of the cell. Together with other thiol redox couples,
such as Trx-SH/Trx-SS, GSH/GSSG acts as a sensor of intracellular redox changes and couples these
modifications to redox-dependent biochemical processes [7]. What are the mechanisms by which
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GSH/GSSG plays a role in signaling? Keeping in mind that the GSH/GSSG couple is the main
determinant of H2O2 level, which is a well-known intracellular messenger in signal transduction (see
reviews [8–13]), it can play a direct role in signaling through glutathionylation, that is, the formation
of mixed disulfides between its cysteine and the cysteine of a protein [14]. As for the processes
regulated by phosphorylation, the redox-mediated signal impacts proteins through a specific amino
acid residue (i.e., cysteine). Several modifications of the thiol group can occur for structural needs,
such as inter/intrachain disulfide –SS–, or different degrees of oxidative stress, such as the sulfenic
–SOH, sulfinic –SO2H, sulfonic –SO3H, and mixed disulfide with cysteine or glutathione –SSR [15]. A
prerequisite for cysteine residue modification is its accessibility by the solvent and a peculiar reactivity
imposed by near amino acids. Indeed, the pK value of the cysteine thiol group is around 8.0 and,
therefore, always protonated at physiological pH. The so-called “reactive cysteine”, instead, is localized
in a basic milieu that stabilizes the thiolated form –S− and represents a very reactive group. The
formation of glutathionylated proteins (GSSPs) has been known for many years. Initially considered
an effect of oxidative stress and damage [16,17], it then became clear that it occurred also under
physiological conditions and, being a reversible process, could have a role in redox signaling [18–20].
GSSPs can be formed by different biochemical reactions: through the formation of sulfenic acids
(reaction below (1)) or the thiol–disulfide exchange that occurs between GSSG and protein thiols (2).
The reaction can be reversibly catalyzed by different enzymes belonging to the family of thiol–disulfide
oxidoreductases or redoxins, including glutaredoxin (Grx) [21], where reversibility and catalysis are
important requirements for the regulatory role of the process [22,23].
(1) PSOH + GSH GSSP + H2O
(2) PSH + GSSG GSSP + GSH
redoxins
It is known that several proteins undergo glutathionylation, resulting in different biological
effects [23,24]. Most studies on the identification of glutathionylated proteins have focused on cellular
proteins, including proteins involved in host response to infections, but there is a growing number of
reports showing that microbial proteins also undergo glutathionylation [25].
Therefore, this review is an attempt to highlight the signaling role of GSH through glutathionylation,
particularly focusing on microbial GSSPs and host GSSPs involved in the immune/inflammatory
response to infection.
2. Glutathionylation in Infections
2.1. Viral Infections
It is well known that viruses alter the intracellular redox state to pro-oxidant conditions, which is
an alteration that contributes to viral pathogenesis [26–31]. Thus, researchers have been evaluating
redox signaling as a potential target for antiviral strategies [32–38]. Virus-induced redox imbalance has
been measured in terms of ROS overproduction and/or GSH depletion in different viral infections,
with different kinetics and mechanisms according to the type of virus and cell host [39–46]. Based
on what has been discussed so far—protein glutathionylation is a physiological process amplified by
oxidative stress, and viruses induce a redox imbalance towards a pro-oxidant state—it is not surprising
to wonder if glutathionylated proteins are detectable during viral infections and if viral proteins
themselves undergo glutathionylation.
The first evidence for viral protein glutathionylation was provided by Davis et al. in 1996 [47].
In fact, they showed that HIV protease contains two cysteines, which are highly conserved among
clinical isolates, that could form mixed disulfides with low-molecular-weight (LMW) thiols, including
GSH, and that this post-translational modification changes the enzyme activity [47]. HIV protease
activity could be regulated through the glutathionylation of these two conserved cysteines by human
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thioltransferase or glutaredoxin, which has been detected in HIV virions [48]. So, the fine regulation
of protease activity may promote optimal viral replication [49]. Interestingly, the finding that the
protease of another retrovirus, HTLV-1, could be regulated by reversible oxidation in a similar way
to that observed for HIV protease led to the idea that this could be an important evolutionarily
conserved mechanism that could prevent the premature activation of retroviral proteases in infected
cells—detrimental for the cells and the virus—and promote their activation later in the virus life
cycle at the optimal timing for viral maturation and budding [50]. More recently, glutathionylation of
chikungunya virus nsP2 protein has been described [51]. In particular, both the recombinant protein
and the viral protein in chikungunya-infected cells have been shown to undergo glutathionylation.
Interestingly, as well as retrovirus proteases, the glutathionylated protein showed lower protease
activity, although the six cysteines identified as being glutathionylated are not in the protease active
site. This suggested that glutathionylation induces conformational changes in the protein that can
also affect sites far from those that have been glutathionylated, and in this way, affect protein function.
Moreover, and again in a similar way to that observed in retrovirus, the specific timing in which the
authors observed the modification suggests that the glutathionylation/deglutathionylation process
switches the protein function for the progression of the virus life cycle. The same authors showed that
dengue and Zika NS5 proteins were glutathionylated in three cysteines and that the post-translational
modification reduced the guanylyltransferase activity of the enzyme from both viruses. The fact that
the cysteines found to be glutathionylated are highly conserved across more flaviviruses also led these
authors to suggest that glutathionylation may be a general mechanism for this family of viruses to
regulate NS5 activities. However, how this modification alters the multiple other functions of the
protein and how this could affect viral replication remain to be elucidated [52]. Finally, we have data
(Checconi et al., unpublished) supporting the glutathionylation of influenza virus proteins that led us
to strongly share the hypothesis that the glutathionylation/deglutathionylation process could be an
important, common mechanism of redox regulation in the replication of more families of viruses.
The cellular redox proteome responds through modifications, in particular of cysteines, to
environmental challenges, such as viruses [53]. Glutathionylation of cellular proteins during viral
infections has been reported since 1997. Indeed, Ciriolo et al. [42] measured a significant amount
of glutathione-mixed disulfides in epithelial cells infected by Sendai, a parainfluenza virus [42].
Ghezzi et al. [54] measured the rate of protein glutathionylation/deglutathionylation in HIV-infected T
lymphocytes, showing that HIV infection made the dethiolation process slower, and the effect was
reverted by the addition of the antioxidant N-acetylcysteine (NAC) [54]. Subsequent studies identified
several of these proteins that undergo glutathionylation during viral infections; interestingly, some
of them belong to pathways involved in the cellular response to infection. It has been reported that
interferon regulatory factor 3 (IRF3) is deglutathionylated by Grx during Sendai virus infection to
efficiently activate the transcription of interferon genes and therefore the innate immune response
to the virus [55]. In the same line, it has been shown that HSV infection induced the production
of ROS that mediate the glutathionylation of proteins belonging to the TRAF family, in particular,
TRAF3 and TRAF6, which are essential for the proper activation of the antiviral innate immune
response [56]. Among the functions influenced by the cysteine proteome, there is also protein
secretion [57]. Thanks to a redox proteomic technique based on the use of biotinylated glutathione, a set
of proteins, including redoxins such as peroxiredoxins (PRDXs) and thioredoxin (TRX), was found by
our group to be released in glutathionylated form by lipopolisaccharide (LPS)-stimulated macrophages
and influenza-virus-infected cells [31]. We can speculate that these GSSPs could have a role in the
pathogenesis of influenza, as PRDX2 has been demonstrated to be a danger signal in an inflammatory
setting [58]. Moreover, a redistribution of key antioxidant enzymes, including PRDX6, in lung cell types
was already observed during influenza pneumonia in mice [59]. Thioredoxin deserves special attention,
as it is a redox enzyme that has long been studied in the context of infection and inflammation [60,61],
including those from influenza virus. In particular, Go et al. [62] demonstrated that TRX1 localization
in cell nuclei increased the severity of the disease and lethality in influenza-virus-infected mice by
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activation of redox-sensitive inflammatory transcription factors; on the other hand, the overexpression
of TRX or the administration of recombinant TRX, or a serum albumin-TRX fusion protein, in mice
has been shown to ameliorate the outcome of influenza virus lung injury [63–65]. These apparent
opposite results indicate the importance of redox compartmentalization [66] and suggest that reductive
stress, as well as oxidative stress, can contribute to disease mechanisms due to the disruption of redox
signaling and control, more so than the increase in reducing or oxidizing species themselves.
Finally, it must be borne in mind that a significant proportion of the “immunopeptidome”, that is,
the peptides stimulating immune cells, have been shown to contain glutathionylated cysteines, with
consequences for antigen presentation/T-cell recognition. It has been reported that glutathionylation
of a coronavirus peptide reduced CD8 T-cell recognition, so this could be a redox mechanism for the
virus to negatively impact the immune response [67].
2.2. Bacteria
Growing evidence highlights the importance of LMW thiols and GSH in bacteria [25,68]. GSH is
present in Gram-negative and some Gram-positive bacteria (i.e., Listeria monocytogenes and Streptococcus
agalactiae), while other Gram-positive bacteria produce LMW thiols, such as bacillithiol (BSH) and
mycothiol (MSH), with similar functions. These functions, as in eukaryotic cells, include detoxification
of different reactive species to maintain the redox balance of the bacteria cytoplasm. Recently,
however, the direct role of GSH in virulence has been described for different bacteria. For example,
it has been shown that GSH activates virulence gene expression in the intracellular pathogen L.
monocytogenes [69]. Similarly, BSH has been shown to be involved in the virulence of some clinical
isolates of methicillin-resistant Staphylococcus aureus [70,71], and MSH is essential for the growth and
survival of Mycobacterium tuberculosis during infection [72].
Thanks to advances in proteomic studies, a growing number of bacteria proteins have been
identified to be S-glutathionylated, S-bacillithiolated, or S-mycothiolated, making it plausible that
S-thiolation could be the mechanism of redox regulation for these proteins. In Salmonella typhimurium, a
top-down proteomic approach identified over 500 proteins with 1665 post-translational modifications,
among which 25 were s-thiolation. Interestingly, nine s-glutathionylated proteins switched to
s-cysteinylation under infection-like conditions, suggesting that this shift could be a novel redox
mechanism of infection control [73]. Portman et al. [74] demonstrated that the cytolysin listeriolysin O
(LLO), a pore-forming virulence factor of L. monocytogenes, is reversibly inhibited by glutathionylation.
Interestingly, a mutant of LLO unable to undergo this post-translational modification was less virulent
in vivo, suggesting that the modification could be important to restrict the pore-forming capability to
an appropriate temporal and/or spatial compartment during infection.
Regarding cellular proteins involved in the response to bacterial infection, the death receptor Fas,
known to be activated by several pathogens, including Pseudomonas aeruginosa, has been shown to be
glutathionylated after caspase-dependent cleavage of Grx1. Glutathionylation of Fas then resulted
in an amplification of apoptosis [75]. In a subsequent study, the same authors demonstrated Fas
glutathionylation in patients with P. aeruginosa pneumonia, showing that the modification promoted
bacteria clearance. Overall, these results indicate the importance of the Grx1/Fas glutathionylation
axis in the resolution of the disease [76]. Recently, it was found that GSH metabolism affects host
cytokine production in response to Borrelia burgdorferi infection, possibly through glutathionylation.
Moreover, GSH-related metabolites have been found to be altered in patients with early onset of Lyme
disease and these alterations persist for months after primary infection. Thus, it has been suggested
that GSH metabolism and glutathionylation could be important processes in the pathogenesis of the B.
burgdorferi-induced Lyme disease and, potentially, other inflammatory diseases as well [77].
3. Glutathionylation in Inflammation
The final section of this review is dedicated to a brief analysis of glutathionylation in inflammation,
focusing on nuclear factor kappa β transcription factor (NFκB)’s glutathionylation.
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NFκB is a transcription factor that plays an important role in the activation of proinflammatory
response. Under physiological conditions, NFκB is sequestered in the cytoplasm in a latent form
by inhibitor κB (IκB). After phosphorylation by IκB kinase (IKK), IκB undergoes degradation via
proteasomes and NFκB is then free to move into the nucleus, where it induces transcription of
proinflammatory genes. Various studies have shown that glutathionylation, through the bond of GSH
to the DNA binding domain, is able to regulate the activity of many transcription factors, including
NFκB [78,79]. In particular, the p65 subunit of NFκB has been reported to be glutathionylated
in different conditions, such as after supplementation of GSH, which leads to DNA binding
inhibition [79]. It has been also demonstrated that the treatment of endothelial cells with an
electrophilic compound (cinnamaldehyde) induced p65-glutathionylation, leading to the inhibition
of TNF-α-induced p65 nuclear translocation and ICAM-1 expression [80]. During treatment with
cinnamaldehyde, the authors also observed an increase of Grx1 protein level. The downregulation
of Grx1 abolished p65-glutathionylation and blocked the inhibition of its nuclear translocation and
ICAM-1 expression, suggesting that the enzyme is involved in cinnamaldehyde-mediated NFκB
inhibition. In a subsequent study, it was shown that treatment with another electrophilic compound,
15-deoxy-∆12,14-prostaglandin J (2) (15d-PGJ (2)), caused p65-glutathionylation, again suppressing
p65 nuclear translocation and the expression of ICAM-1, thus working as an anti-inflammatory
molecule [81]. Treatment of hepatocytes with H2O2 also induced p65-glutathionylation and its
retention in the cytoplasm, leading to an increase of the apoptotic rate of hepatocytes [82]. Besides p65,
S-glutathionylation was also observed for the p50 subunit of NFκB on Cys-62. This post-translational
modification reversibly inhibited its DNA binding activity [83].
Moreover, IKK, the protein responsible for IκB phosphorylation and NFκB translocation to the
nucleus, can be inactivated by S-glutathionylation of Cys-179 [84]. So, the NFκB complex, as well as
upstream proteins such as TRAF6, is negatively regulated via glutathionylation [85]. In these two studies,
it was shown that knockdown of Grx1 hampered IKK and TRAF6 deglutathionylation, respectively,
and reduced NFκB activation, indicating the importance of Grx1-mediated deglutathionylation in
modulating the NFκB signaling pathway [85]. Moreover, both p65 and IKKa have been shown to
be regulated by the Grx1/glutathionylation axis in IL-17A-stimulated epithelial cells, contributing to
IL-17A-induced proinflammatory response [86].
Jones et al. [87] demonstrated that glutathione S-transferase (GSTP) is another enzyme capable
of inducing the S-glutathionylation of many proteins under conditions of oxidative stress. The
authors highlighted that, in unstimulated cells, GSTP bound the NFκB inhibitor, IκBα, while exposure
to LPS led to their dissociation. LPS treatment also induced GSTP association with IKKβ and
IKKβ-S-glutathionylation to increase. The inhibition of GSTP with siRNA, causing a decrease in
IKKβ-S-glutathionylation, enhanced NFκB nuclear translocation, its transcriptional activity, and
production of proinflammatory cytokines [87].
Finally, we have to mention that interleukin-1β, together with a group of cytokines, has been
shown to undergo glutathionylation itself [88]. In particular, the authors demonstrated that IL-1β
glutathionylation at the conserved cysteine Cys-188 protected it from ROS deactivation, making it
necessary for maintaining cytokine bioactivity. Grx1 is the physiological negative regulator of the
glutathionylation process, and it has been suggested to be a new potential therapeutic target in the
treatment of various infectious and inflammatory diseases.
Figure 1 is a schematic picture of the glutathionylated proteins described in this review, and
Figure 2 summarizes the effects of glutathionylation on those proteins.
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4. Conclusions
In this review, we underscored the role of glutathionylation in viral/bacterial infections and host
response. It is well known that infections, particularly viral infections, cause a redox imbalance towards
pro-oxidant conditions in the cell, and we believe that glutathionylation fits into these virus-induced
changes to regulate its replication and/or cell response. However, based on the available knowledge,
we may speculate that the glutathionylation/deglutathionylation process is not a mere consequence
of the oxidative burst but a finer regulation of the different phases of viral replication. In particular,
glutathionylation could inhibit the premature activation of some viral protein functions, as in the
case of retroviral proteases, which would be harmful for the cells and the virus and promote their
activation at the optimal timing for viral maturation and spread. In a similar way, the process could
play a role in bacterial infections, representing a potential mechanism of virulence. At the same time,
the inflammatory cell response to infections could be affected, for example, by the redox processes
regarding NFκB activation. This nuclear transcription factor was among the first identified to be redox
modulated and strictly involved in inflammation, viral replication, and cell proliferation/apoptosis.
The transient glutathionylation of NFκB could also take part in the regulatory processes committed
by infections.
Overall, a deeper knowledge of the chemical and regulatory processes through which
glutathionylation occurs could pave the way for the identification of novel targets to control microbial
infections and related host responses.
Author Contributions: P.C. and D.L. literature search, draft preparation, writing and editing of the manuscript,
equally contributions to the work; S.B., M.R.C., L.N. and A.T.P. reviewing and editing; L.N. and A.T.P. supervision
and funding acquisition.
Funding: This work was partially supported by the Italian Ministry of Instruction, Universities and
Research—MIUR PRIN 2017KM79NN (PC), PRIN 2017WJBKKW (DL), Ateneo 2016 and MIUR PRIN
2017BMK8JR006 (ATP, LN) grants.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Meister, A. On the discovery of glutathione. Trends Biochem. Sci. 1988, 13, 185–188. [CrossRef]
2. Dickinson, D.A.; Forman, H.J. Cellular glutathione and thiols metabolism. Biochem. Pharmacol. 2002, 64,
1019–1026. [CrossRef]
3. Forman, H.J.; Zhang, H.; Rinna, A. Glutathione: Overview of its protective roles, measurement, and
biosynthesis. Mol. Asp. Med. 2009, 30, 1–12. [CrossRef] [PubMed]
4. Aquilano, K.; Baldelli, S.; Ciriolo, M.R. Glutathione: New roles in redox signaling for an old antioxidant.
Front. Pharmacol. 2014, 5, 196. [CrossRef] [PubMed]
5. Fratelli, M.; Goodwin, L.O.; Orom, U.A.; Lombardi, S.; Tonelli, R.; Mengozzi, M.; Ghezzi, P. Gene expression
profiling reveals a signaling role of glutathione in redox regulation. Proc. Natl. Acad. Sci. USA 2005, 102,
13998–14003. [CrossRef] [PubMed]
6. Diotallevi, M.; Checconi, P.; Palamara, A.T.; Celestino, I.; Coppo, L.; Holmgren, A.; Abbas, K.; Peyrot, F.;
Mengozzi, M.; Ghezzi, P. Glutathione fine-tunes the innate immune response toward antiviral pathways in a
macrophage cell line independently of its antioxidant properties. Front. Immunol. 2017, 8, 1239. [CrossRef]
[PubMed]
7. Schafer, F.Q.; Buettner, G.R. Redox environment of the cell as viewed through the redox state of the glutathione
disulfide/glutathione couple. Free Radic. Biol. Med. 2001, 30, 1191–1212. [CrossRef]
8. Rhee, S.G.; Kang, S.W.; Jeong, W.; Chang, T.S.; Yang, K.S.; Woo, H.A. Intracellular messenger function of
hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 2005, 17, 183–189. [CrossRef]
[PubMed]
9. Forman, H.J.; Maiorino, M.; Ursini, F. Signaling functions of reactive oxygen species. Biochemistry 2010, 49,
835–842. [CrossRef] [PubMed]
Nutrients 2019, 11, 1952 8 of 12
10. Marinho, H.S.; Real, C.; Cyrne, L.; Soares, H.; Antunes, F. Hydrogen peroxide sensing, signaling and
regulation of transcription factors. Redox Biol. 2014, 2, 535–562. [CrossRef] [PubMed]
11. Sies, H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative
eustress. Redox Biol. 2017, 11, 613–619. [CrossRef] [PubMed]
12. Di Marzo, N.; Chisci, E.; Giovannoni, R. The role of hydrogen peroxide in redox-dependent signaling:
Homeostatic and pathological responses in mammalian cells. Cells 2018, 7, 156. [CrossRef] [PubMed]
13. Finkel, T. Signal transduction by reactive oxygen species. J. Cell Biol. 2011, 194, 7–15. [CrossRef] [PubMed]
14. Fratelli, M.; Demol, H.; Puype, M.; Casagrande, S.; Eberini, I.; Salmona, M.; Bonetto, V.; Mengozzi, M.;
Duffieux, F.; Miclet, E.; et al. Identification by redox proteomics of glutathionylated proteins in oxidatively
stressed human T lymphocytes. Proc. Natl. Acad. Sci. USA 2002, 99, 3505–3510. [CrossRef] [PubMed]
15. Filomeni, G.; Rotilio, G.; Ciriolo, M.R. Disulfide relays and phosphorylative cascades: Partners in
redox-mediated signaling pathways. Cell Death Differ. 2005, 12, 1555–1563. [CrossRef] [PubMed]
16. Brigelius, R.; Lenzen, R.; Sies, H. Increase in hepatic mixed disulphide and glutathione disulphide levels
elicited by paraquat. Biochem. Pharmacol. 1982, 31, 1637–1641. [CrossRef]
17. Brigelius, R.; Muckel, C.; Akerboom, T.P.; Sies, H. Identification and quantitation of glutathione in hepatic
protein mixed disulfides and its relationship to glutathione disulfide. Biochem. Pharmacol. 1983, 32, 2529–2534.
[CrossRef]
18. Sies, H.; Brigelius, R.; Graf, P. Hormones, glutathione status and protein S-thiolation. Adv. Enzym. Regul.
1987, 26, 175–189. [CrossRef]
19. Giustarini, D.; Rossi, R.; Milzani, A.; Colombo, R.; Dalle-Donne, I. S-glutathionylation: From redox regulation
of protein functions to human diseases. J. Cell. Mol. Med. 2004, 8, 201–212. [CrossRef]
20. Ghezzi, P.; Bonetto, V.; Fratelli, M. Thiol-disulfide balance: From the concept of oxidative stress to that of
redox regulation. Antioxid. Redox Signal. 2005, 7, 964–972. [CrossRef]
21. Lillig, C.H.; Berndt, C. Glutaredoxins in thiol/disulfide exchange. Antioxid. Redox Signal. 2013, 18, 1654–1665.
[CrossRef] [PubMed]
22. Shelton, M.D.; Chock, P.B.; Mieyal, J.J. Glutaredoxin: Role in reversible protein s-glutathionylation and
regulation of redox signal transduction and protein translocation. Antioxid. Redox Signal. 2005, 7, 348–366.
[CrossRef] [PubMed]
23. Ghezzi, P. Protein glutathionylation in health and disease. Biochim. Biophys. Acta 2013, 1830, 3165–3172.
[CrossRef] [PubMed]
24. Pastore, A.; Piemonte, F. S-Glutathionylation signaling in cell biology: Progress and prospects. Eur. J. Pharm.
Sci. 2012, 46, 279–292. [CrossRef] [PubMed]
25. Dalle-Donne, I.; Rossi, R.; Colombo, G.; Giustarini, D.; Milzani, A. Protein S-glutathionylation: A regulatory
device from bacteria to humans. Trends Biochem. Sci. 2009, 34, 85–96. [CrossRef] [PubMed]
26. Beck, M.A.; Handy, J.; Levander, O.A. The role of oxidative stress in viral infections. Ann. N. Y. Acad. Sci.
2000, 917, 906–912. [CrossRef]
27. Akaike, T. Role of free radicals in viral pathogenesis and mutation. Rev. Med. Virol. 2001, 11, 87–101.
[CrossRef]
28. Ivanov, A.V.; Valuev-Elliston, V.T.; Ivanova, O.N.; Kochetkov, S.N.; Starodubova, E.S.; Bartosch, B.;
Isaguliants, M.G. Oxidative stress during HIV infection: Mechanisms and consequences. Oxidative Med. Cell.
Longev. 2016, 2016, 8910396. [CrossRef]
29. Limongi, D.; Baldelli, S. Redox imbalance and viral infections in neurodegenerative diseases. Oxidative Med.
Cell. Longev. 2016, 2016, 6547248. [CrossRef]
30. Anticoli, S.; Amatore, D.; Matarrese, P.; De Angelis, M.; Palamara, A.T.; Nencioni, L.; Ruggieri, A.
Counteraction of HCV-induced oxidative stress concurs to establish chronic infection in liver cell cultures.
Oxidative Med. Cell. Longev. 2019, 2019, 6452390.
31. Checconi, P.; Salzano, S.; Bowler, L.; Mullen, L.; Mengozzi, M.; Hanschmann, E.M.; Lillig, C.H.; Sgarbanti, R.;
Panella, S.; Nencioni, L.; et al. Redox proteomics of the inflammatory secretome identifies a common set
of redoxins and other glutathionylated proteins released in inflammation, influenza virus infection and
oxidative stress. PLoS ONE 2015, 10, e0127086. [CrossRef] [PubMed]
Nutrients 2019, 11, 1952 9 of 12
32. Sgarbanti, R.; Nencioni, L.; Amatore, D.; Coluccio, P.; Fraternale, A.; Sale, P.; Mammola, C.L.; Carpino, G.;
Gaudio, E.; Magnani, M.; et al. Redox regulation of the influenza hemagglutinin maturation process: A
new cell-mediated strategy for anti-influenza therapy. Antioxid. Redox Signal. 2011, 15, 593–606. [CrossRef]
[PubMed]
33. Nencioni, L.; Sgarbanti, R.; Amatore, D.; Checconi, P.; Celestino, I.; Limongi, D.; Anticoli, S.; Palamara, A.T.;
Garaci, E. Intracellular redox signaling as therapeutic target for novel antiviral strategy. Curr. Pharm. Des.
2011, 17, 3898–3904. [CrossRef] [PubMed]
34. Vlahos, R.; Stambas, J.; Bozinovski, S.; Broughton, B.R.; Drummond, G.R.; Selemidis, S. Inhibition of Nox2
oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog. 2011, 7, e1001271.
[CrossRef] [PubMed]
35. To, E.E.; Vlahos, R.; Luong, R.; Halls, M.L.; Reading, P.C.; King, P.T.; Chan, C.; Drummond, G.R.; Sobey, C.G.;
Broughton, B.R.S.; et al. Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for
antiviral therapy. Nat. Commun. 2017, 8, 69. [CrossRef]
36. Khomich, O.A.; Kochetkov, S.N.; Bartosch, B.; Ivanov, A.V. Redox biology of respiratory viral infections.
Viruses 2018, 10, 392. [CrossRef]
37. Bizzarri, B.M.; Botta, L.; Capecchi, E.; Celestino, I.; Checconi, P.; Palamara, A.T.; Nencioni, L.; Saladino, R.
Regioselective IBX-mediated synthesis of coumarin derivatives with antioxidant and anti-influenza activities.
J. Nat. Prod. 2017, 80, 3248–3255. [CrossRef]
38. Akaike, T.; Maeda, H. Nitric oxide and virus infection. Immunology 2000, 101, 300–308. [CrossRef]
39. Oda, T.; Akaike, T.; Hamamoto, T.; Suzuki, F.; Hirano, T.; Maeda, H. Oxygen radicals in influenza-induced
pathogenesis and treatment with pyran polymer-conjugated SOD. Science 1989, 244, 974–976. [CrossRef]
40. Palamara, A.T.; Perno, C.F.; Ciriolo, M.R.; Dini, L.; Balestra, E.; D’Agostini, C.; Di Francesco, P.; Favalli, C.;
Rotilio, G.; Garaci, E. Evidence for antiviral activity of glutathione: In vitro inhibition of herpes simplex
virus type 1 replication. Antivir. Res. 1995, 27, 237–253. [CrossRef]
41. Palamara, A.T.; Perno, C.F.; Aquaro, S.; Bue, M.C.; Dini, L.; Garaci, E. Glutathione inhibits HIV replication
by acting at late stages of the virus life cycle. AIDS Res. Hum. Retrovir. 1996, 12, 1537–1541. [CrossRef]
[PubMed]
42. Ciriolo, M.R.; Palamara, A.T.; Incerpi, S.; Lafavia, E.; Bue, M.C.; De Vito, P.; Garaci, E.; Rotilio, G. Loss of
GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection. J. Biol. Chem.
1997, 272, 2700–2708. [CrossRef] [PubMed]
43. Garaci, E.; Palamara, A.T.; Ciriolo, M.R.; D’Agostini, C.; Abdel-Latif, M.S.; Aquaro, S.; Lafavia, E.; Rotilio, G.
Intracellular GSH content and HIV replication in human macrophages. J. Leukoc. Biol. 1997, 62, 54–59.
[CrossRef] [PubMed]
44. Herzenberg, L.A.; De Rosa, S.C.; Dubs, J.G.; Roederer, M.; Anderson, M.T.; Ela, S.W.; Deresinski, S.C.;
Herzenberg, L.A. Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl.
Acad. Sci. USA 1997, 94, 1967–1972. [CrossRef] [PubMed]
45. Checconi, P.; Sgarbanti, R.; Celestino, I.; Limongi, D.; Amatore, D.; Iuvara, A.; Alimonti, A.; Garaci, E.;
Palamara, A.T.; Nencioni, L. The environmental pollutant cadmium promotes influenza virus replication in
MDCK cells by altering their redox state. Int. J. Mol. Sci. 2013, 14, 4148–4162. [CrossRef] [PubMed]
46. Amatore, D.; Sgarbanti, R.; Aquilano, K.; Baldelli, S.; Limongi, D.; Civitelli, L.; Nencioni, L.; Garaci, E.;
Ciriolo, M.R.; Palamara, A.T. Influenza virus replication in lung epithelial cells depends on redox-sensitive
pathways activated by NOX4-derived ROS. Cell. Microbiol. 2015, 17, 131–145. [CrossRef] [PubMed]
47. Davis, D.A.; Dorsey, K.; Wingfield, P.T.; Stahl, S.J.; Kaufman, J.; Fales, H.M.; Levine, R.L. Regulation of HIV-1
protease activity through cysteine modification. Biochemistry 1996, 35, 2482–2488. [CrossRef] [PubMed]
48. Davis, D.A.; Newcomb, F.M.; Starke, D.W.; Ott, D.E.; Mieyal, J.J.; Yarchoan, R. Thioltransferase (glutaredoxin)
is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J. Biol.
Chem. 1997, 272, 25935–25940. [CrossRef]
49. Davis, D.A.; Yusa, K.; Gillim, L.A.; Newcomb, F.M.; Mitsuya, H.; Yarchoan, R. Conserved cysteines of the
human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and
viral maturation of immature virions. J. Virol. 1999, 73, 1156–1164.
50. Davis, D.A.; Brown, C.A.; Newcomb, F.M.; Boja, E.S.; Fales, H.M.; Kaufman, J.; Stahl, S.J.; Wingfield, P.;
Yarchoan, R. Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization
and activation. J. Virol. 2003, 77, 3319–3325. [CrossRef]
Nutrients 2019, 11, 1952 10 of 12
51. Saisawang, C.; Kuadkitkan, A.; Smith, D.R.; Ubol, S.; Ketterman, A.J. Glutathionylation of chikungunya nsP2
protein affects protease activity. Biochim. Biophys. Acta 2017, 1861, 106–111. [CrossRef] [PubMed]
52. Saisawang, C.; Kuadkitkan, A.; Auewarakul, P.; Smith, D.R.; Ketterman, A.J. Glutathionylation of dengue
and Zika NS5 proteins affects guanylyltransferase and RNA dependent RNA polymerase activities. PLoS
ONE 2018, 13, e0193133. [CrossRef] [PubMed]
53. Go, Y.M.; Jones, D.P. The redox proteome. J. Biol. Chem. 2013, 288, 26512–26520. [CrossRef] [PubMed]
54. Ghezzi, P.; Romines, B.; Fratelli, M.; Eberini, I.; Gianazza, E.; Casagrande, S.; Laragione, T.; Mengozzi, M.;
Herzenberg, L.A.; Herzenberg, L.A. Protein glutathionylation: Coupling and uncoupling of glutathione
to protein thiol groups in lymphocytes under oxidative stress and HIV infection. Mol. Immunol. 2002, 38,
773–780. [CrossRef]
55. Prinarakis, E.; Chantzoura, E.; Thanos, D.; Spyrou, G. S-glutathionylation of IRF3 regulates IRF3-CBP
interaction and activation of the IFN beta pathway. EMBO J. 2008, 27, 865–875. [CrossRef]
56. Gonzalez-Dosal, R.; Horan, K.A.; Rahbek, S.H.; Ichijo, H.; Chen, Z.J.; Mieyal, J.J.; Hartmann, R.; Paludan, S.R.
HSV infection induces production of ROS, which potentiate signaling from pattern recognition receptors:
Role for S-glutathionylation of TRAF3 and 6. PLoS Pathog. 2011, 7, e1002250. [CrossRef] [PubMed]
57. Go, Y.M.; Chandler, J.D.; Jones, D.P. The cysteine proteome. Free Radic. Biol. Med. 2015, 84, 227–245.
[CrossRef]
58. Salzano, S.; Checconi, P.; Hanschmann, E.M.; Lillig, C.H.; Bowler, L.D.; Chan, P.; Vaudry, D.; Mengozzi, M.;
Coppo, L.; Sacre, S.; et al. Linkage of inflammation and oxidative stress via release of glutathionylated
peroxiredoxin-2, which acts as a danger signal. Proc. Natl. Acad. Sci. USA 2014, 111, 12157–12162. [CrossRef]
59. Yamada, Y.; Limmon, G.V.; Zheng, D.; Li, N.; Li, L.; Yin, L.; Chow, V.T.; Chen, J.; Engelward, B.P. Major shifts
in the spatio-temporal distribution of lung antioxidant enzymes during influenza pneumonia. PLoS ONE
2012, 7, e31494. [CrossRef]
60. Nakamura, H.; De Rosa, S.; Roederer, M.; Anderson, M.T.; Dubs, J.G.; Yodoi, J.; Holmgren, A.;
Herzenberg, L.A.; Herzenberg, L.A. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int.
Immunol. 1996, 8, 603–611. [CrossRef]
61. Bertini, R.; Howard, O.M.; Dong, H.F.; Oppenheim, J.J.; Bizzarri, C.; Sergi, R.; Caselli, G.; Pagliei, S.;
Romines, B.; Wilshire, J.A.; et al. Thioredoxin, a redox enzyme released in infection and inflammation,
is a unique chemoattractant for neutrophils, monocytes, and T cells. J. Exp. Med. 1999, 189, 1783–1789.
[CrossRef] [PubMed]
62. Go, Y.M.; Kang, S.M.; Roede, J.R.; Orr, M.; Jones, D.P. Increased inflammatory signaling and lethality of
influenza H1N1 by nuclear thioredoxin-1. PLoS ONE 2011, 6, e18918. [CrossRef]
63. Nakamura, H.; Tamura, S.; Watanabe, I.; Iwasaki, T.; Yodoi, J. Enhanced resistancy of thioredoxin-transgenic
mice against influenza virus-induced pneumonia. Immunol. Lett. 2002, 82, 165–170. [CrossRef]
64. Yashiro, M.; Tsukahara, H.; Matsukawa, A.; Yamada, M.; Fujii, Y.; Nagaoka, Y.; Tsuge, M.; Yamashita, N.;
Ito, T.; Yamada, M.; et al. Redox-active protein thioredoxin-1 administration ameliorates influenza A virus
(H1N1)-induced acute lung injury in mice. Crit. Care Med. 2013, 41, 171–181. [CrossRef] [PubMed]
65. Tanaka, R.; Ishima, Y.; Enoki, Y.; Kimachi, K.; Shirai, T.; Watanabe, H.; Chuang, V.T.; Maruyama, T.; Otagiri, M.
Therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung
injury mice. Front. Immunol. 2014, 5, 561. [CrossRef] [PubMed]
66. Go, Y.M.; Jones, D.P. Redox compartmentalization in eukaryotic cells. Biochim. Biophys. Acta 2008, 1780,
1273–1290. [CrossRef] [PubMed]
67. Trujillo, J.A.; Croft, N.P.; Dudek, N.L.; Channappanavar, R.; Theodossis, A.; Webb, A.I.; Dunstone, M.A.;
Illing, P.T.; Butler, N.S.; Fett, C.; et al. The cellular redox environment alters antigen presentation. J. Biol.
Chem. 2014, 289, 27979–27991. [CrossRef] [PubMed]
68. Loi, V.V.; Rossius, M.; Antelmann, H. Redox regulation by reversible protein S-thiolation in bacteria. Front.
Microbiol. 2015, 6, 187. [CrossRef] [PubMed]
69. Reniere, M.L.; Whiteley, A.T.; Hamilton, K.L.; John, S.M.; Lauer, P.; Brennan, R.G.; Portnoy, D.A. Glutathione
activates virulence gene expression of an intracellular pathogen. Nature 2015, 517, 170–173. [CrossRef]
70. Pother, D.C.; Gierok, P.; Harms, M.; Mostertz, J.; Hochgrafe, F.; Antelmann, H.; Hamilton, C.J.; Borovok, I.;
Lalk, M.; Aharonowitz, Y.; et al. Distribution and infection-related functions of bacillithiol in Staphylococcus
aureus. Int. J. Med. Microbiol. 2013, 303, 114–123. [CrossRef] [PubMed]
Nutrients 2019, 11, 1952 11 of 12
71. Posada, A.C.; Kolar, S.L.; Dusi, R.G.; Francois, P.; Roberts, A.A.; Hamilton, C.J.; Liu, G.Y.; Cheung, A.
Importance of bacillithiol in the oxidative stress response of staphylococcus aureus. Infect. Immun. 2014, 82,
316–332. [CrossRef] [PubMed]
72. Sassetti, C.M.; Rubin, E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad.
Sci. USA 2003, 100, 12989–12994. [CrossRef] [PubMed]
73. Ansong, C.; Wu, S.; Meng, D.; Liu, X.; Brewer, H.M.; Deatherage Kaiser, B.L.; Nakayasu, E.S.; Cort, J.R.;
Pevzner, P.; Smith, R.D.; et al. Top-down proteomics reveals a unique protein S-thiolation switch in Salmonella
Typhimurium in response to infection-like conditions. Proc. Natl. Acad. Sci. USA 2013, 110, 10153–10158.
[CrossRef] [PubMed]
74. Portman, J.L.; Huang, Q.Y.; Reniere, M.L.; Iavarone, A.T.; Portnoy, D.A. Activity of the pore-forming virulence
factor listeriolysin O is reversibly inhibited by naturally occurring S-glutathionylation. Infect. Immun. 2017,
85, e00959-16. [CrossRef] [PubMed]
75. Anathy, V.; Aesif, S.W.; Guala, A.S.; Havermans, M.; Reynaert, N.L.; Ho, Y.S.; Budd, R.C.;
Janssen-Heininger, Y.M. Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1
and S-glutathionylation of Fas. J. Cell Biol. 2009, 184, 241–252. [CrossRef] [PubMed]
76. Anathy, V.; Aesif, S.W.; Hoffman, S.M.; Bement, J.L.; Guala, A.S.; Lahue, K.G.; Leclair, L.W.; Suratt, B.T.;
Cool, C.D.; Wargo, M.J.; et al. Glutaredoxin-1 attenuates S-glutathionylation of the death receptor fas and
decreases resolution of Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 2014, 189,
463–474. [CrossRef] [PubMed]
77. Kerstholt, M.; Vrijmoeth, H.; Lachmandas, E.; Oosting, M.; Lupse, M.; Flonta, M.; Dinarello, C.A.; Netea, M.G.;
Joosten, L.A.B. Role of glutathione metabolism in host defense against Borrelia burgdorferi infection. Proc.
Natl. Acad. Sci. USA 2018, 115, E2320–E2328. [CrossRef] [PubMed]
78. Klatt, P.; Molina, E.P.; De Lacoba, M.G.; Padilla, C.A.; Martinez-Galesteo, E.; Barcena, J.A.; Lamas, S. Redox
regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J. 1999, 13, 1481–1490. [CrossRef]
79. Qanungo, S.; Starke, D.W.; Pai, H.V.; Mieyal, J.J.; Nieminen, A.L. Glutathione supplementation potentiates
hypoxic apoptosis by S-glutathionylation of p65-NFkappaB. J. Biol. Chem. 2007, 282, 18427–18436. [CrossRef]
80. Liao, B.C.; Hsieh, C.W.; Lin, Y.C.; Wung, B.S. The glutaredoxin/glutathione system modulates NF-kappaB
activity by glutathionylation of p65 in cinnamaldehyde-treated endothelial cells. Toxicol. Sci. 2010, 116,
151–163. [CrossRef]
81. Lin, Y.C.; Huang, G.D.; Hsieh, C.W.; Wung, B.S. The glutathionylation of p65 modulates NF-kappa B
activity in 15-deoxy-Delta,(12,14)-prostaglandin J(2)-treated endothelial cells. Free Radic. Biol. Med. 2012, 52,
1844–1853. [CrossRef] [PubMed]
82. Alisi, A.; Pastore, A.; Passarelli, C.; Tozzi, G.; Bottazzo, G.F.; Nobili, V.; Piemonte, F. Glutathionylation of
p65NF-KB correlates with proliferating/apoptotic hepatoma cells exposed to pro- and anti-oxidants. Free
Radic. Res. 2009, 43, 59.
83. Pineda-Molina, E.; Klatt, P.; Vazquez, J.; Marina, A.; de Lacoba, M.G.; Perez-Sala, D.; Lamas, S.
Glutathionylation of the p50 subunit of NF-kappa B: A mechanism for redox-induced inhibition of DNA
binding. Biochemistry 2001, 40, 14134–14142. [CrossRef] [PubMed]
84. Reynaert, N.L.; van der Vliet, A.; Guala, A.S.; McGovern, T.; Hristova, M.; Pantano, C.; Heintz, N.H.; Heim, J.;
Ho, Y.S.; Matthews, D.E.; et al. Dynamic redox control of NF-kappa B through glutaredoxin-regulated
S-glutathionylation of inhibitory kappa B kinase beta. Proc. Natl. Acad. Sci. USA 2006, 103, 13086–13091.
[CrossRef] [PubMed]
85. Chantzoura, E.; Prinarakis, E.; Panagopoulos, D.; Mosialos, G.; Spyrou, G. Glutaredoxin-1 regulates TRAF6
activation and the IL-1 receptor/TLR4 signalling. Biochem. Biophys. Res. Commun. 2010, 403, 335–339.
[CrossRef] [PubMed]
86. Nolin, J.D.; Tully, J.E.; Hoffman, S.M.; Guala, A.S.; van der Velden, J.L.; Poynter, M.E.; van der
Vliet, A.; Anathy, V.; Janssen-Heininger, Y.M. The glutaredoxin/S-glutathionylation axis regulates
interleukin-17A-induced proinflammatory responses in lung epithelial cells in association with
S-glutathionylation of nuclear factor kappaB family proteins. Free Radic. Biol. Med. 2014, 73, 143–153.
[CrossRef] [PubMed]
Nutrients 2019, 11, 1952 12 of 12
87. Jones, J.T.; Qian, X.; van der Velden, J.L.J.; Chia, S.B.; McMillan, D.H.; Flemer, S.; Hoffman, S.M.; Lahue, K.G.;
Schneider, R.W.; Nolin, J.D.; et al. Glutathione S-transferase pi modulates NF-kappa B activation and
pro-inflammatory responses in lung epithelial cells. Redox Biol. 2016, 8, 375–382. [CrossRef]
88. Zhang, X.; Liu, P.; Zhang, C.; Chiewchengchol, D.; Zhao, F.; Yu, H.; Li, J.; Kambara, H.; Luo, K.Y.;
Venkataraman, A.; et al. Positive regulation of interleukin-1beta bioactivity by physiological ROS-mediated
cysteine S-glutathionylation. Cell Rep. 2017, 20, 224–235. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
